Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities
- PMID: 12355370
- DOI: 10.1086/343816
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities
Abstract
Cervical human papillomavirus (HPV) infections are at high risk of neoplastic progression if they persist. Persistence can be measured by repeated HPV DNA tests or by cytologic testing. Thus, it is useful to understand the relationship between these 2 measurements. To explore the relative timing of HPV DNA clearance versus cytologic regression, data were analyzed from 840 study participants who were followed-up by repeat thin-layer cytology and HPV testing by a hybrid capture test at 6-month intervals for 2 years. On average, HPV DNA detection persisted longer than related cytologic abnormalities (P<.001). HPV type-specific data from a subset of 448 women with complete polymerase chain reaction test data confirmed that HPV DNA persisted longer than cytologic abnormalities (P<.001). It appears that the natural history of HPV typically includes periods before and after cytologic abnormality, in which HPV DNA is the more sensitive indicator of infection.
Similar articles
-
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.Int J STD AIDS. 2003 Jun;14(6):417-25. doi: 10.1258/095646203765371321. Int J STD AIDS. 2003. PMID: 12816671
-
HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.Am Fam Physician. 1999 May 15;59(10):2794-801. Am Fam Physician. 1999. PMID: 10348071 Review.
-
Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.J Med Virol. 2002 Jun;67(2):246-52. doi: 10.1002/jmv.2214. J Med Virol. 2002. PMID: 11992586
-
Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.Gynecol Oncol. 2007 Nov;107(2):231-5. doi: 10.1016/j.ygyno.2007.06.025. Epub 2007 Sep 14. Gynecol Oncol. 2007. PMID: 17854873
-
Diagnosis of human papillomavirus gynecologic infections.Clin Lab Med. 2000 Jun;20(2):271-87, vi. Clin Lab Med. 2000. PMID: 10863641 Review.
Cited by
-
Human papillomavirus testing in the prevention of cervical cancer.J Natl Cancer Inst. 2011 Mar 2;103(5):368-83. doi: 10.1093/jnci/djq562. Epub 2011 Jan 31. J Natl Cancer Inst. 2011. PMID: 21282563 Free PMC article. Review.
-
Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.Clin Epigenetics. 2019 Oct 12;11(1):140. doi: 10.1186/s13148-019-0743-9. Clin Epigenetics. 2019. PMID: 31606044 Free PMC article.
-
Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.J Clin Microbiol. 2012 Jul;50(7):2359-65. doi: 10.1128/JCM.00337-12. Epub 2012 Apr 18. J Clin Microbiol. 2012. PMID: 22518863 Free PMC article.
-
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.J Clin Microbiol. 2006 Feb;44(2):571-9. doi: 10.1128/JCM.44.2.571-579.2006. J Clin Microbiol. 2006. PMID: 16455914 Free PMC article.
-
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.J Clin Microbiol. 2007 Jul;45(7):2130-7. doi: 10.1128/JCM.02438-06. Epub 2007 May 9. J Clin Microbiol. 2007. PMID: 17494721 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources